Scintigraphic evidence for the regression of skeletal metastases from a hypernephroma following long-term treatment with medroxyprogesterone acetate.
D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D011877:Radionuclide Imaging
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone